Changing Pattern of Hospital Admissions of Children With Sickle Cell Disease Over the Last 50 Years

被引:8
作者
Day, Thomas G. [1 ,2 ,3 ]
Thein, Swee Lay [3 ,4 ]
Drasar, Emma [3 ,4 ]
Dick, Moira C. [5 ]
Height, Susan E. [5 ]
O'Driscoll, Sandra [5 ]
Rees, David C. [5 ]
机构
[1] Barnet & Chase Farm Hosp NHS Trust, Barnet Hosp, Neonatal Unit, London EN5 3DJ, England
[2] Chase Farm Hosp NHS Trust, London, England
[3] Kings Coll London, Sch Med, Div Gene & Cell Based Therapy, London WC2R 2LS, England
[4] Kings Coll Hosp NHS Fdn Trust, Dept Haematol Med, London, England
[5] Kings Coll Hosp NHS Fdn Trust, Dept Paediat Hematol, London, England
基金
英国医学研究理事会;
关键词
sickle cell disease; pediatrics; epidemiology; TRANSCRANIAL DOPPLER; RANDOMIZED TRIAL; RISK-FACTORS; ANEMIA; HYDROXYUREA; ENGLAND; LONDON; STROKE; LIFE;
D O I
10.1097/MPH.0b013e31822543f4
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
A study published in 1981 examined the causes of hospital admission for a cohort of children with sickle cell disease (SCD). Since that time, the incidence and prevalence of SCD has increased markedly in the UK, and there have been many changes in the management of this disease. We undertook a study examining the causes of hospital admission of children with SCD to the same hospital as the previous study, over the 2-year period from 2008 to 2009. We found that the numbers of children being cared for by our hospital had dramatically increased over the last 50 years, but rates of hospital admission had significantly fallen (41 hospital admissions per 100 patient-years, compared with 111.3 admissions per 100 patient-years in the original study). This fall in admission rates is accounted for by 2 major components: acute painful episodes (15.7 admissions per 100 patient-years compared with 39.3 in the previous study) and admission for elective blood transfusion (0.2 admissions per 100 patient-years compared with 26.7 in the previous study). It is interesting to note that, 541 elective transfusions were carried out during the study period, but in a day-care setting rather than requiring overnight admission. This study illustrates the changes in management of SCD over the past 30 years, and reflects the overall trend common to most hospital specialties of increasing community and ambulatory care.
引用
收藏
页码:491 / 495
页数:5
相关论文
共 17 条
[1]   Effectiveness of the 7-valent pneumococcal conjugate vaccine in children with sickle cell disease in the first decade of life [J].
Adamkiewicz, Thomas V. ;
Silk, Benjamin J. ;
Howgate, James ;
Baughman, Wendy ;
Strayhorn, Gregory ;
Sullivan, Kevin ;
Farley, Monica M. .
PEDIATRICS, 2008, 121 (03) :562-569
[2]   Long-term stroke risk in children with sickle cell disease screened with transcranial Doppler [J].
Adams, RJ ;
McKie, VC ;
Carl, EM ;
Nichols, FT ;
Perry, R ;
Brock, K ;
McKie, K ;
Figueroa, R ;
Litaker, M ;
Weiner, S ;
Brambilla, D .
ANNALS OF NEUROLOGY, 1997, 42 (05) :699-704
[3]   Prevention of a first stroke by transfusions in children with sickle, cell anemia and abnormal results on transcranial Doppler ultrasonography [J].
Adams, RJ ;
McKie, VC ;
Hsu, L ;
Files, B ;
Vichinsky, E ;
Pegelow, C ;
Abboud, M ;
Gallagher, D ;
Kutlar, A ;
Nichols, FT ;
Bonds, DR ;
Brambilla, D ;
Woods, G ;
Olivieri, N ;
Driscoll, C ;
Miller, S ;
Wang, W ;
Hurlett, A ;
Scher, C ;
Berman, B ;
Carl, E ;
Jones, AM ;
Roach, ES ;
Wright, E ;
Zimmerman, RA ;
Waclawiw, M ;
Pearson, H ;
Powars, D ;
Younkin, D ;
El-Gammal, T ;
Seibert, J ;
Moye, L ;
Espeland, M ;
Murray, R ;
McKinley, R ;
McKinley, S ;
Hagner, S ;
Weiner, S ;
Estow, S ;
Yelle, M ;
Brock, K ;
Carter, E ;
Chiarucci, K ;
Debarr, M ;
Feron, P ;
Harris, S ;
Hoey, L ;
Jacques, K ;
Kuisel, L ;
Lewis, N .
NEW ENGLAND JOURNAL OF MEDICINE, 1998, 339 (01) :5-11
[4]   ACUTE ADMISSIONS OF PATIENTS WITH SICKLE-CELL DISEASE WHO LIVE IN BRITAIN [J].
BROZOVIC, M ;
DAVIES, SC ;
BROWNELL, AI .
BRITISH MEDICAL JOURNAL, 1987, 294 (6581) :1206-1208
[5]   Hydroxyurea and sickle cell anemia - Clinical utility of a myelosuppressive ''switching'' agent [J].
Charache, S ;
Barton, FB ;
Moore, RD ;
Terrin, ML ;
Steinberg, MH ;
Dover, GJ ;
Ballas, SK ;
McMahon, RP ;
Castro, O ;
Orringer, EP ;
Jones, S ;
Strayhorn, D ;
Rosse, W ;
Phillips, G ;
Peace, D ;
JohnsonTelfair, A ;
Milner, P ;
Kutlar, A ;
Tracy, A ;
Allen, GE ;
Moshang, J ;
Steinberg, M ;
Anderson, A ;
Sabahi, V ;
Pegelow, C ;
Temple, D ;
Case, E ;
Harrell, R ;
Embury, S ;
Schmidt, B ;
Koshy, M ;
TalischyZahed, N ;
Dorn, L ;
Pendarvis, G ;
McGee, M ;
Telfer, M ;
Davis, A ;
Finke, H ;
Perlin, E ;
Siteman, J ;
Gascon, P ;
diPaolo, P ;
Gargiulo, S ;
Eckman, J ;
Bailey, JH ;
Platt, A ;
Waller, L ;
Ramirez, G ;
Knors, V ;
Hernandez, S .
MEDICINE, 1996, 75 (06) :300-326
[6]   Managing sickle cell disease [J].
Claster, S ;
Vichinsky, EP .
BRITISH MEDICAL JOURNAL, 2003, 327 (7424) :1151-1155
[7]   Hydroxyurea for treatment of severe sickle cell anemia: A pediatric clinical trial [J].
Ferster, A ;
Vermylen, C ;
Cornu, G ;
Buyse, M ;
Corazza, F ;
Devalck, C ;
Fondu, P ;
Toppet, M ;
Sariban, E .
BLOOD, 1996, 88 (06) :1960-1964
[8]   PROPHYLAXIS WITH ORAL PENICILLIN IN CHILDREN WITH SICKLE-CELL-ANEMIA - A RANDOMIZED TRIAL [J].
GASTON, MH ;
VERTER, JI ;
WOODS, G ;
PEGELOW, C ;
KELLEHER, J ;
PRESBURY, G ;
ZARKOWSKY, H ;
VICHINSKY, E ;
IYER, R ;
LOBEL, JS ;
DIAMOND, S ;
HOLBROOK, CT ;
GILL, FM ;
RITCHEY, K ;
FALLETTA, JM .
NEW ENGLAND JOURNAL OF MEDICINE, 1986, 314 (25) :1593-1599
[9]   The role of hydroxyurea in sickle cell disease [J].
Halsey, C ;
Roberts, IAG .
BRITISH JOURNAL OF HAEMATOLOGY, 2003, 120 (02) :177-186
[10]   Randomised trial of oral morphine for painful episodes of sickle-cell disease in children [J].
Jacobson, SJ ;
Kopecky, EA ;
Joshi, P ;
Babul, N .
LANCET, 1997, 350 (9088) :1358-1361